RegeneRx Biopharmaceuticals's ticker is RGRX and the CUSIP is 75886X108. A total of 1 filers reported holding RegeneRx Biopharmaceuticals in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170 | -36.1% | 10,000 | 0.0% | 0.00% | – |
| Q2 2023 | $266 | -74.7% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $1,050 | -24.4% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,389 | +38.9% | 10,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -94.1% | 10,000 | -95.2% | 0.00% | – |
| Q4 2021 | $34,000 | -2.9% | 210,000 | 0.0% | 0.00% | – |
| Q3 2021 | $35,000 | -38.6% | 210,000 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $57,000 | +7.5% | 210,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $53,000 | -43.0% | 210,000 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $93,000 | +16.2% | 210,000 | +5.0% | 0.00% | +100.0% |
| Q3 2020 | $80,000 | +27.0% | 200,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $63,000 | +65.8% | 200,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $38,000 | +35.7% | 200,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $28,000 | +27.3% | 200,000 | +42.9% | 0.00% | – |
| Q3 2019 | $22,000 | – | 140,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Williams Jones Wealth Management, LLC. | 10,000 | $2,000 | 0.00% |